PrintBio
1 known investors
PrintBio is a clinical- and commercial-stage biotechnology company developing 3D-bioprinting and material science technologies to create bioresorbable surgical mesh products, including its DynaFlex and DynaForm Programmable Surgical Mesh lines for soft tissue repair and reinforcement. Working with surgeons, the company also builds living tissue implants for patients in regenerative medicine.